cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.7kr3fb
title: Occurrence Download

description: A dataset containing 1 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Macaca cyclopis",
 "Country is Japan",
 "HasCoordinate is true"
 ]
}

 The dataset includes 1 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0009937-250802193616735/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.33zjrp
title: Occurrence Download

description: A dataset containing 3278 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Silene flos-cuculi",
 "Country is United States of America",
 "HasCoordinate is true"
 ]
}

 The dataset includes 3278 records from 43 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0009938-250802193616735/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.a6t4sk
title: Occurrence Download

description: A dataset containing 2773 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Cirrhitus pinnulatus"
 ]
}

 The dataset includes 2773 records from 100 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0009939-250802193616735/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.tep8f4
title: Occurrence Download

description: A dataset containing 317 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Imparfinis schubarti)",
 "BasisOfRecord is one of (Specimen, Literature Occurrence, Human Observation, Observation)",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "Year is greater than or equal to 1991",
 "Year is less than or equal to 2025"
 ]
}

 The dataset includes 317 records from 10 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0009940-250802193616735/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.n8upgu
title: Occurrence Download

description: A dataset containing 5 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Argemone mexicana",
 "Country is Netherlands",
 "HasCoordinate is true"
 ]
}

 The dataset includes 5 records from 4 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0009941-250802193616735/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.uydqyx
title: Occurrence Download

description: A dataset containing 52 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Eichhornia crassipes",
 "HasCoordinate is true",
 "Country is Nigeria"
 ]
}

 The dataset includes 52 records from 11 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0009942-250802193616735/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.5yubd2
title: Occurrence Download

description: A dataset containing 5 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Ephedra major",
 "Geometry POLYGON ((26.04335 1.226334, 135.0263 1.226334, 135.0263 55.38525, 26.04335 55.38525, 26.04335 1.226334))",
 "HasCoordinate is true"
 ]
}

 The dataset includes 5 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0009943-250802193616735/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.c6qvvd
title: Occurrence Download

description: A dataset containing 43 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Crocidura dsinezumi",
 "Country is Japan",
 "HasCoordinate is true"
 ]
}

 The dataset includes 43 records from 9 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0009945-250802193616735/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.ven26v
title: Occurrence Download

description: A dataset containing 969 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is China",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is one of (Zanthoxylum, Zanthoxylum sicyoides, Zanthoxylum externum, Zanthoxylum novoguineense, Zanthoxylum duplicipunctatum)",
 "Year 2000-2023"
 ]
}

 The dataset includes 969 records from 32 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0009944-250802193616735/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.e7hcq4
title: Occurrence Download

description: A dataset containing 740 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Silene noctiflora",
 "Country is United States of America",
 "HasCoordinate is true"
 ]
}

 The dataset includes 740 records from 84 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0009946-250802193616735/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.m42y4j
title: Occurrence Download

description: A dataset containing 78 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Cirrhitus spilotoceps"
 ]
}

 The dataset includes 78 records from 4 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0009947-250802193616735/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.g3axh8
title: Occurrence Download

description: A dataset containing 4490 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Benin",
 "OccurrenceStatus is Present",
 "TaxonKey is Parkia biglobosa"
 ]
}

 The dataset includes 4490 records from 73 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0009948-250802193616735/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dd.rkrxp2
title: Test for derived dataset

description: This data was filtered using a fake protocol
DOI: 10.15468/dd.trazqn
title: Test for derived dataset

description: This data was filtered using a fake protocol
DOI: 10.6084/m9.figshare.20424212
title: Association between health literacy and COVID-19 prevention behaviors among pregnant and postpartum women

description: To investigate the association between health literacy and COVID-19 prevention behaviors among pregnant and postpartum women in Japan. In this cross-sectional, web-based, self-reported questionnaire survey, we investigated the association between health literacy and COVID-19 prevention behaviors among pregnant and postpartum women in Japan. A multivariable logistic regression analysis was performed to evaluate the association with adjustment for socioeconomic characteristics. There were 926 respondents, comprising 368 pregnant and 558 postpartum women. Women with high health literacy scores accounted for 42% of the respondents. This group had a significantly higher proportion of actively adopting preventive behaviors than the low health literacy group (33.5 <i>vs.</i> 25.4%, <i>p</i> = .008). The multivariable logistic regression analysis showed high health literacy was significantly associated with high preventive behaviors scores compared to low health literacy (adjusted odds ratio, 1.66; 95% confidence interval, 1.22–2.27). Higher health literacy was significantly associated with a higher proportion of COVID-19 prevention behaviors among women who are pregnant or postpartum.
DOI: 10.6084/m9.figshare.20424212.v1
title: Association between health literacy and COVID-19 prevention behaviors among pregnant and postpartum women

description: To investigate the association between health literacy and COVID-19 prevention behaviors among pregnant and postpartum women in Japan. In this cross-sectional, web-based, self-reported questionnaire survey, we investigated the association between health literacy and COVID-19 prevention behaviors among pregnant and postpartum women in Japan. A multivariable logistic regression analysis was performed to evaluate the association with adjustment for socioeconomic characteristics. There were 926 respondents, comprising 368 pregnant and 558 postpartum women. Women with high health literacy scores accounted for 42% of the respondents. This group had a significantly higher proportion of actively adopting preventive behaviors than the low health literacy group (33.5 <i>vs.</i> 25.4%, <i>p</i> = .008). The multivariable logistic regression analysis showed high health literacy was significantly associated with high preventive behaviors scores compared to low health literacy (adjusted odds ratio, 1.66; 95% confidence interval, 1.22–2.27). Higher health literacy was significantly associated with a higher proportion of COVID-19 prevention behaviors among women who are pregnant or postpartum.
DOI: 10.6084/m9.figshare.14804897
title: A goal set too high: factors associated with planning excess gestational weight gain in a prospective cohort study

description: This study aimed to understand physical, knowledge, psychological, and lifestyle factors associated with planned excess gestational weight gain (GWG), a strong and potentially modifiable predictor of actual excess GWG, which contributes to maternal and child obesity along with other adverse maternal and fetal outcomes. This is a secondary analysis of data from a prospective cohort study where women completed a questionnaire in early pregnancy. Women were asked to report their planned GWG, which was then categorized as above, within, or below the Institute of Medicine (IOM) guidelines. Univariable and multivariable analyses were performed to identify variables associated with planned excess GWG. Of 970 women included in the analysis, 300 reported a planned GWG above the IOM guidelines. Predictors of excess planned GWG included reporting healthcare provider recommendations to gain weight above the guidelines (adjusted odds ratio [aOR], 62.17; 95% confidence interval [CI], 13.75–281.03), overestimating first trimester weight gain recommendations (aOR, 1.83; 95% CI, 1.21–2.77), believing in risks to the baby with inadequate GWG (aOR 2.16; 95% CI,1.29–3.60), inaccurate self-perceived prepregnancy body size (aOR, 1.88; 95% CI, 1.22–2.89), low or high emotional suppression (aOR, 1.78; 95% CI, 1.06–2.99; and aOR, 2.57; 95% CI, 1.21–5.45, respectively), physical inactivity (aOR, 1.10; 95% CI, 1.03–1.17), and overweight or obesity (aOR, 5.76; 95% CI, 3.70–8.98; and aOR, 11.46; 95% CI, 6.54–20.06, respectively). Protective factors against planned excess GWG included increased maternal age (aOR, 0.95; 95% CI, 0.92–0.99), and believing in risks to themselves with inadequate GWG (aOR 0.64; 95% CI, 0.42–0.97) or believing in risks to the baby with excess GWG (aOR, 0.49; 95% CI, 0.27–0.88). Women with overweight or obesity are at greater risk of prospectively planning excess GWG, and may especially benefit from healthcare provider counseling on appropriate GWG. Other modifiable factors for planned excess GWG included knowledge about risks of inappropriate weight gain and physical inactivity.
DOI: 10.6084/m9.figshare.14804897.v1
title: A goal set too high: factors associated with planning excess gestational weight gain in a prospective cohort study

description: This study aimed to understand physical, knowledge, psychological, and lifestyle factors associated with planned excess gestational weight gain (GWG), a strong and potentially modifiable predictor of actual excess GWG, which contributes to maternal and child obesity along with other adverse maternal and fetal outcomes. This is a secondary analysis of data from a prospective cohort study where women completed a questionnaire in early pregnancy. Women were asked to report their planned GWG, which was then categorized as above, within, or below the Institute of Medicine (IOM) guidelines. Univariable and multivariable analyses were performed to identify variables associated with planned excess GWG. Of 970 women included in the analysis, 300 reported a planned GWG above the IOM guidelines. Predictors of excess planned GWG included reporting healthcare provider recommendations to gain weight above the guidelines (adjusted odds ratio [aOR], 62.17; 95% confidence interval [CI], 13.75–281.03), overestimating first trimester weight gain recommendations (aOR, 1.83; 95% CI, 1.21–2.77), believing in risks to the baby with inadequate GWG (aOR 2.16; 95% CI,1.29–3.60), inaccurate self-perceived prepregnancy body size (aOR, 1.88; 95% CI, 1.22–2.89), low or high emotional suppression (aOR, 1.78; 95% CI, 1.06–2.99; and aOR, 2.57; 95% CI, 1.21–5.45, respectively), physical inactivity (aOR, 1.10; 95% CI, 1.03–1.17), and overweight or obesity (aOR, 5.76; 95% CI, 3.70–8.98; and aOR, 11.46; 95% CI, 6.54–20.06, respectively). Protective factors against planned excess GWG included increased maternal age (aOR, 0.95; 95% CI, 0.92–0.99), and believing in risks to themselves with inadequate GWG (aOR 0.64; 95% CI, 0.42–0.97) or believing in risks to the baby with excess GWG (aOR, 0.49; 95% CI, 0.27–0.88). Women with overweight or obesity are at greater risk of prospectively planning excess GWG, and may especially benefit from healthcare provider counseling on appropriate GWG. Other modifiable factors for planned excess GWG included knowledge about risks of inappropriate weight gain and physical inactivity.
DOI: 10.6084/m9.figshare.17103076
title: Prevalence of methylmalonic acidemia among newborns and the clinical-suspected population: a meta-analyse

description: Knowing the scale of rare inborn errors is important for screening and resource allocation. Evidence on the prevalence of methylmalonic acidemia (MMA) among newborns and the clinical-suspected population from large-scale screening programs needs to be systematically synthesized. To estimate the worldwide prevalence of MMA for newborns and the clinical-suspected population and explore the differences in different regions, periods, and diagnostic technologies. MEDLINE, Embase, CRD, Cochrane Library, Scopus, CINAHL, and PROSPERO. Study Selection: All studies reporting the epidemiology characteristics of MMA were selected. Characteristics of study, subjects, and epidemiology were extracted, random-effect models were used for meta-analyses. Pooled prevalence of MMA. This study included 111 studies. The pooled prevalence of MMA worldwide was 1.14 per 100,000 newborns (1516/190,229,777 newborns, 95% CI: 0.99–1.29) and 652.11 per 100,000 clinical-suspected patients (1360/4,805,665 clinical-suspected individuals, CI: 544.14–760.07). Asia and Africa got a higher pooled prevalence of MMA. The prevalence of MMA in newborns increased through the years, while that in the clinical-suspected population decreased. Collecting blood ≥ 72 h after birth had a higher pooled prevalence of MMA than collecting during 24 h–72 h after birth. The combining-use of MS/MS and GC/MS had a higher pooled prevalence than the single-use of MS/MS or GC/MS. Prevalence of cbl C, mut, cbl B, cbl A, isolated MMA, combined MMA and homocystinuria, vitamin B12-responsive MMA was synthesized. Prevalence of MMA among newborns was extremely low, but considerably high in the clinical-suspected population, indicating the need for more efficient newborn screening strategies and closer monitoring of the high-risk population for the early signs of MMA. Asia and Africa should attach importance to the high prevalence of MMA. Further diagnostic tests were recommended for the combining-use vs single-use of MS/MS and GC/MS and for collecting blood after 72 h vs during 24–72 h after birth.
DOI: 10.6084/m9.figshare.17103076.v2
title: Prevalence of methylmalonic acidemia among newborns and the clinical-suspected population: a meta-analyse

description: Knowing the scale of rare inborn errors is important for screening and resource allocation. Evidence on the prevalence of methylmalonic acidemia (MMA) among newborns and the clinical-suspected population from large-scale screening programs needs to be systematically synthesized. To estimate the worldwide prevalence of MMA for newborns and the clinical-suspected population and explore the differences in different regions, periods, and diagnostic technologies. MEDLINE, Embase, CRD, Cochrane Library, Scopus, CINAHL, and PROSPERO. Study Selection: All studies reporting the epidemiology characteristics of MMA were selected. Characteristics of study, subjects, and epidemiology were extracted, random-effect models were used for meta-analyses. Pooled prevalence of MMA. This study included 111 studies. The pooled prevalence of MMA worldwide was 1.14 per 100,000 newborns (1516/190,229,777 newborns, 95% CI: 0.99–1.29) and 652.11 per 100,000 clinical-suspected patients (1360/4,805,665 clinical-suspected individuals, CI: 544.14–760.07). Asia and Africa got a higher pooled prevalence of MMA. The prevalence of MMA in newborns increased through the years, while that in the clinical-suspected population decreased. Collecting blood ≥ 72 h after birth had a higher pooled prevalence of MMA than collecting during 24 h–72 h after birth. The combining-use of MS/MS and GC/MS had a higher pooled prevalence than the single-use of MS/MS or GC/MS. Prevalence of cbl C, mut, cbl B, cbl A, isolated MMA, combined MMA and homocystinuria, vitamin B12-responsive MMA was synthesized. Prevalence of MMA among newborns was extremely low, but considerably high in the clinical-suspected population, indicating the need for more efficient newborn screening strategies and closer monitoring of the high-risk population for the early signs of MMA. Asia and Africa should attach importance to the high prevalence of MMA. Further diagnostic tests were recommended for the combining-use vs single-use of MS/MS and GC/MS and for collecting blood after 72 h vs during 24–72 h after birth.
DOI: 10.6084/m9.figshare.16456083
title: A standardized post-cesarean analgesia regimen reduces postpartum opioid use

description: Optimal post-cesarean pain control is important. With the rising opioid epidemic it is imperative to maximize non-opioid based primary approaches to post-cesarean pain control. In 2018, we implemented a standardized post-cesarean analgesia regimen. To determine if implementation of a standardized postoperative analgesic regimen decreases opioid use following cesarean birth. A standardized postoperative analgesia protocol was implemented in June 2018, which included scheduled oral acetaminophen (975 mg every 6 h) and nonsteroidal anti-inflammatory drugs (NSAIDs) (ketorolac 15 mg IV every 6 h for 5 doses followed by ibuprofen 600 mg oral every 6 h) with opioids available for breakthrough pain. There was no prior standardized protocol. A before-and-after study design was used to compare oral morphine milligram equivalents (MME) for nine months prior to and nine months after this protocol was implemented, excluding the two month period of protocol rollout. Women with opioid use disorder or postoperative intubation were excluded. The primary outcome was the cumulative MME used in the first 72 h postoperatively. Total dose at 12, 24, and 48 h were also compared. Of 2340 women who underwent cesarean birth during the study period (1 July 2017 − 30 April 2019), 2001 women met inclusion criteria (914 before 10 April 2018 (pre-protocol) and 1087 after 17 June 2018 (post-protocol)). Baseline characteristics of the two groups were similar, including gestational age at delivery, maternal body mass index (BMI), planned versus unplanned cesarean birth, and type of intraoperative anesthesia used. The cumulative opioid dose in the first 72 h postoperatively was 216.3 ± 84.3 MME prior to implementation compared to 171.5 ± 91.5 MME following implementation (<i>p</i> &lt; .001). The average cumulative MME use was higher in the pre-protocol period compared to post-protocol at all time periods: 12 h (57.3 ± 23.8 vs 48.6 ± 26.2 MME, <i>p</i> &lt; .001), 24 h (98.1 ± 34.1 vs 82.1 ± 38.8 MME, <i>p</i> &lt; .001), and 48 h (165.8 ± 58.3 vs 134.9 ± 66.2 MME, <i>p</i> &lt; .001). The average pain scores were lower in the pre-protocol group (3 vs 3.3, <i>p</i> &lt; .001). Scheduled administration of acetaminophen and NSAIDs following cesarean birth significantly decreased the cumulative dose of opioids used in the first 72 h postoperatively.
DOI: 10.6084/m9.figshare.16456083.v1
title: A standardized post-cesarean analgesia regimen reduces postpartum opioid use

description: Optimal post-cesarean pain control is important. With the rising opioid epidemic it is imperative to maximize non-opioid based primary approaches to post-cesarean pain control. In 2018, we implemented a standardized post-cesarean analgesia regimen. To determine if implementation of a standardized postoperative analgesic regimen decreases opioid use following cesarean birth. A standardized postoperative analgesia protocol was implemented in June 2018, which included scheduled oral acetaminophen (975 mg every 6 h) and nonsteroidal anti-inflammatory drugs (NSAIDs) (ketorolac 15 mg IV every 6 h for 5 doses followed by ibuprofen 600 mg oral every 6 h) with opioids available for breakthrough pain. There was no prior standardized protocol. A before-and-after study design was used to compare oral morphine milligram equivalents (MME) for nine months prior to and nine months after this protocol was implemented, excluding the two month period of protocol rollout. Women with opioid use disorder or postoperative intubation were excluded. The primary outcome was the cumulative MME used in the first 72 h postoperatively. Total dose at 12, 24, and 48 h were also compared. Of 2340 women who underwent cesarean birth during the study period (1 July 2017 − 30 April 2019), 2001 women met inclusion criteria (914 before 10 April 2018 (pre-protocol) and 1087 after 17 June 2018 (post-protocol)). Baseline characteristics of the two groups were similar, including gestational age at delivery, maternal body mass index (BMI), planned versus unplanned cesarean birth, and type of intraoperative anesthesia used. The cumulative opioid dose in the first 72 h postoperatively was 216.3 ± 84.3 MME prior to implementation compared to 171.5 ± 91.5 MME following implementation (<i>p</i> &lt; .001). The average cumulative MME use was higher in the pre-protocol period compared to post-protocol at all time periods: 12 h (57.3 ± 23.8 vs 48.6 ± 26.2 MME, <i>p</i> &lt; .001), 24 h (98.1 ± 34.1 vs 82.1 ± 38.8 MME, <i>p</i> &lt; .001), and 48 h (165.8 ± 58.3 vs 134.9 ± 66.2 MME, <i>p</i> &lt; .001). The average pain scores were lower in the pre-protocol group (3 vs 3.3, <i>p</i> &lt; .001). Scheduled administration of acetaminophen and NSAIDs following cesarean birth significantly decreased the cumulative dose of opioids used in the first 72 h postoperatively.